申请人:SJT MOLECULAR RESEARCH, S.L.
公开号:US20160340355A1
公开(公告)日:2016-11-24
Present invention refers to new compounds of formula I or II, its synthesis and its use in the treatment of metabolic syndrome, particularly for the treatment of type I or type II diabetes and/or metabolic syndrome or metabolic disease or metabolic disorders.